DZ2209A1 - Procédé pour la préparation d'un sel de magnésium d'un hétérocycle sulfinyle substitué. - Google Patents

Procédé pour la préparation d'un sel de magnésium d'un hétérocycle sulfinyle substitué.

Info

Publication number
DZ2209A1
DZ2209A1 DZ970056A DZ970056A DZ2209A1 DZ 2209 A1 DZ2209 A1 DZ 2209A1 DZ 970056 A DZ970056 A DZ 970056A DZ 970056 A DZ970056 A DZ 970056A DZ 2209 A1 DZ2209 A1 DZ 2209A1
Authority
DZ
Algeria
Prior art keywords
preparation
magnesium salt
substituted sulfinyl
heterocycle
sulfinyl heterocycle
Prior art date
Application number
DZ970056A
Other languages
English (en)
French (fr)
Inventor
Jan-Ake Hogberg
Panagiotis Ionnidis
Anders Mattson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20402358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ2209(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of DZ2209A1 publication Critical patent/DZ2209A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DZ970056A 1996-04-26 1997-04-20 Procédé pour la préparation d'un sel de magnésium d'un hétérocycle sulfinyle substitué. DZ2209A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601598A SE508669C2 (sv) 1996-04-26 1996-04-26 Nytt förfarande

Publications (1)

Publication Number Publication Date
DZ2209A1 true DZ2209A1 (fr) 2002-12-03

Family

ID=20402358

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ970056A DZ2209A1 (fr) 1996-04-26 1997-04-20 Procédé pour la préparation d'un sel de magnésium d'un hétérocycle sulfinyle substitué.

Country Status (39)

Country Link
US (1) US6124464A (enExample)
EP (1) EP0897386B1 (enExample)
JP (1) JP4233115B2 (enExample)
KR (1) KR100468331B1 (enExample)
CN (1) CN1100776C (enExample)
AR (1) AR006640A1 (enExample)
AT (1) ATE222904T1 (enExample)
BR (1) BR9708829A (enExample)
CA (1) CA2251636C (enExample)
CZ (1) CZ295067B6 (enExample)
DE (1) DE69714987T2 (enExample)
DK (1) DK0897386T3 (enExample)
DZ (1) DZ2209A1 (enExample)
EE (1) EE03485B1 (enExample)
EG (1) EG23874A (enExample)
ES (1) ES2180981T3 (enExample)
HR (1) HRP970210B1 (enExample)
HU (1) HUP9901798A3 (enExample)
ID (1) ID16685A (enExample)
IL (1) IL126716A (enExample)
IS (1) IS1984B (enExample)
MA (1) MA24143A1 (enExample)
MY (1) MY119011A (enExample)
NO (1) NO318850B1 (enExample)
NZ (1) NZ332154A (enExample)
PL (1) PL188824B1 (enExample)
PT (1) PT897386E (enExample)
RS (1) RS49718B (enExample)
RU (1) RU2163238C2 (enExample)
SA (1) SA97170759B1 (enExample)
SE (1) SE508669C2 (enExample)
SI (1) SI0897386T1 (enExample)
SK (1) SK282752B6 (enExample)
TN (1) TNSN97068A1 (enExample)
TR (1) TR199802156T2 (enExample)
TW (1) TW420676B (enExample)
UA (1) UA51699C2 (enExample)
WO (1) WO1997041114A1 (enExample)
ZA (1) ZA973153B (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875872B1 (en) * 1993-05-28 2005-04-05 Astrazeneca Compounds
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
US6403616B1 (en) * 1998-11-18 2002-06-11 Astrazeneca Ab Chemical process and pharmaceutical formulation
CA2290893C (en) 1999-11-16 2007-05-01 Bernard Charles Sherman Magnesium omeprazole
AU2001276721A1 (en) * 2000-08-04 2002-02-18 Takeda Chemical Industries Ltd. Salts of benzimidazole compound and use thereof
WO2003063840A2 (en) * 2002-01-25 2003-08-07 Santarus, Inc. Transmucosal delivery of proton pump inhibitors
ES2286408T3 (es) * 2002-03-05 2007-12-01 Astrazeneca Ab Sales de alquilamonio de omeprazol e esomeprazol.
TW200410955A (en) * 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
DE10234617B4 (de) * 2002-07-29 2013-04-04 Nycomed Gmbh Neues Salz von (S)-Pantoprazol
EA200500673A1 (ru) * 2002-10-22 2005-12-29 Рэнбакси Лабораториз Лимитед Аморфная форма соли эзомепразола, способ ее получения и фармацевтическая композиция на её основе
US20040242642A1 (en) * 2002-11-18 2004-12-02 Dr. Reddy's Laboratories Limited Crystalline esomeprazole compounds and process for the preparation thereof
EP1572680A2 (en) * 2002-12-19 2005-09-14 Eva Pharmaceutical Industries Ltd. Solid states of pantoprazole sodium, known pantoprazole sodium hydrates, processes for their preparation.
US20060247277A1 (en) * 2003-02-28 2006-11-02 Yatendra Kumar Polymorphs of s-omeprazole
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
CL2004000983A1 (es) 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
WO2005012289A1 (en) * 2003-07-17 2005-02-10 Altana Pharma Ag Novel salt of (r) - pantoprazole
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
SE0302382D0 (sv) * 2003-09-04 2003-09-04 Astrazeneca Ab New salts II
SE0302381D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts I
ITMI20031813A1 (it) * 2003-09-23 2005-03-24 Dinamite Dipharma S P A In Forma A Bbreviata Diph Procedimento per la preparazione di pantoprazolo e suoi sali.
WO2005082888A1 (en) * 2004-03-01 2005-09-09 Milen Merkez Ilac Endustrisi A.S. Process for the preparation of magnesium salt of omeprazole
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
US8779175B2 (en) * 2004-10-25 2014-07-15 Synthonics, Inc. Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
US7799937B2 (en) 2004-10-25 2010-09-21 Synthonics, Inc. Metal coordinated compositions
US20060141054A1 (en) * 2004-10-25 2006-06-29 Thomas Piccariello Metal coordinated compositions
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
US7553857B2 (en) * 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
US20080139623A1 (en) 2006-06-12 2008-06-12 Lilach Hedvati Amorphous and crystalline forms of pantoprazole magnesium salt
EP1947099A1 (en) 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Process for solvent removal from omeprazole salts
JP2010519284A (ja) 2007-02-21 2010-06-03 シプラ・リミテッド エソメプラゾールマグネシウム二水和物の調製方法
US8106210B2 (en) * 2007-10-08 2012-01-31 Hetero Drugs Limited Polymorphs of esomeprazole salts
EP2147918A1 (en) 2008-07-21 2010-01-27 LEK Pharmaceuticals D.D. Process for the preparation of S-omeprazole magnesium in a stable form
WO2010097583A1 (en) 2009-02-24 2010-09-02 Cipla Limited Esomeprazole potassium polymorph and its preparation
US20110207779A1 (en) * 2010-02-25 2011-08-25 Glenmark Generics Ltd Process for the preparation of esomeprazole magnesium
EP2426111A1 (en) 2010-08-09 2012-03-07 Laboratorios Del. Dr. Esteve, S.A. 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride amorphous solid forms
CN103467453A (zh) * 2013-09-13 2013-12-25 上海海虹实业(集团)巢湖今辰药业有限公司 一种奥美拉唑镁原料药制备方法
CN106397399A (zh) * 2015-07-29 2017-02-15 陕西合成药业股份有限公司 一种泮托拉唑镁的精制方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
GB8307865D0 (en) * 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
IL76837A0 (en) * 1984-10-31 1986-02-28 Byk Gulden Lomberg Chem Fab Benzimidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
FI861772L (fi) * 1985-05-07 1986-11-08 Chemie Linz Ag Nya tieno(2,3-d)imidazolderivat och foerfarande for deras framstaellning.
FI864138A7 (fi) * 1985-10-16 1987-04-17 Fisons Plc Heterocykliska blandningar.
DD290192A5 (de) * 1986-11-13 1991-05-23 Eisai Co. Ltd,Jp Pyridinderivat mit antiulzeroeser wirkung
NZ234564A (en) * 1986-11-21 1991-04-26 Haessle Ab 1-substituted benzimidazoles and pharmaceutical compositions
WO1989000566A1 (fr) * 1987-07-21 1989-01-26 Yoshitomi Pharmaceutical Industries, Ltd. Composes de pyridine et leurs utilisations en medecine
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
NZ244301A (en) * 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
KR950701921A (ko) * 1992-06-01 1995-05-17 고야 다다시 피리딘 화합물 및 이의 제약학적 용도(pyridine compound and medicinal use thereof)
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
US5374730A (en) * 1993-11-04 1994-12-20 Torcan Chemical Ltd. Preparation of omeprazole and lansoprazole
DK1078628T3 (da) * 1994-07-08 2009-02-23 Astrazeneca Ab Tabletteret flerenhedsdoseringsform

Also Published As

Publication number Publication date
CA2251636C (en) 2001-04-10
TNSN97068A1 (fr) 1999-12-31
DE69714987D1 (de) 2002-10-02
SE9601598D0 (sv) 1996-04-26
SE9601598L (sv) 1997-10-27
TW420676B (en) 2001-02-01
DE69714987T2 (de) 2003-04-30
UA51699C2 (uk) 2002-12-16
EE9800363A (et) 1999-04-15
ZA973153B (en) 1997-10-27
HRP970210A2 (en) 1998-04-30
JP2000509067A (ja) 2000-07-18
HK1016978A1 (en) 1999-11-12
AU2719397A (en) 1997-11-19
DK0897386T3 (da) 2002-10-28
SE508669C2 (sv) 1998-10-26
AR006640A1 (es) 1999-09-08
JP4233115B2 (ja) 2009-03-04
MY119011A (en) 2005-03-31
KR20000065018A (ko) 2000-11-06
RS49718B (sr) 2007-12-31
AU711345B2 (en) 1999-10-14
NO984903L (no) 1998-10-21
HUP9901798A2 (hu) 2000-04-28
ID16685A (id) 1997-10-30
RU2163238C2 (ru) 2001-02-20
TR199802156T2 (xx) 1999-02-22
CA2251636A1 (en) 1997-11-06
EP0897386A1 (en) 1999-02-24
PT897386E (pt) 2002-12-31
CN1100776C (zh) 2003-02-05
IS4872A (is) 1998-10-19
SA97170759B1 (ar) 2006-09-25
NZ332154A (en) 2002-03-01
NO984903D0 (no) 1998-10-21
ES2180981T3 (es) 2003-02-16
SK282752B6 (sk) 2002-12-03
SK140798A3 (en) 1999-04-13
BR9708829A (pt) 1999-08-03
PL188824B1 (pl) 2005-04-29
PL329683A1 (en) 1999-04-12
MA24143A1 (fr) 1997-12-31
NO318850B1 (no) 2005-05-18
KR100468331B1 (ko) 2005-03-16
EE03485B1 (et) 2001-08-15
HUP9901798A3 (en) 2003-02-28
EP0897386B1 (en) 2002-08-28
SI0897386T1 (en) 2002-12-31
CZ295067B6 (cs) 2005-05-18
IL126716A (en) 2003-10-31
ATE222904T1 (de) 2002-09-15
US6124464A (en) 2000-09-26
EG23874A (en) 2007-11-27
CN1216989A (zh) 1999-05-19
WO1997041114A1 (en) 1997-11-06
YU44898A (sh) 1999-07-28
CZ339898A3 (cs) 1999-03-17
HRP970210B1 (en) 2002-06-30
IL126716A0 (en) 1999-08-17
IS1984B (is) 2005-02-15

Similar Documents

Publication Publication Date Title
MA24143A1 (fr) Procede pour la preparation d'un sel de magnesium d'un heterocycle sulfinyle substitue.
DZ1911A1 (fr) Procédé pour la synthèse de sulfoxydes substitues.
DZ2247A1 (fr) Procédé pour la préparation du sildénafil.
MA23143A1 (fr) Procede pour la preparation de compositions vaccinantes .
EP0661326A3 (en) Process for the production of polyester.
MA21962A1 (fr) Procede pour la preparation d'inhibiteurs de proteass retrovirales .
DZ3079A1 (fr) Procédé pour la préparation de 4-carboxy-amino-2-substitué-1,2,3,4 tétrahydroquinolé.
EP0658587A3 (en) Process for the preparation of polyarylene sulfide.
EP0692505A3 (en) Process for the preparation of propylene block copolymers
EP0744431A3 (en) Process for the production of aromatic polyamides
FR2688235B1 (fr) Procede d'obtention d'hydroxydes metalliques.
FR2741875B1 (fr) Procede pour l'hydroformylation des composes olefiniques
EP0752405A3 (en) Process for the production of phenol
DZ2032A1 (fr) Un procédé pour la préparation de l'hydrochlorure de lercanidipine.
DZ1758A1 (fr) Procédé pour la préparation d'aryl-piperidine carbinols.
DZ1946A1 (fr) Procédé pour la préparation de supports.
DZ2430A1 (fr) Procédé pour la préparation de dérivés de thiazolidinedione substitués.
EP0729938A3 (en) Process for the preparation of aryl-alkyl hydroperoxides
FR2779143B1 (fr) Procede ameliore de preparation d'un sel fondu
DZ2423A1 (fr) Procédé pour la préparation d'acides 4-phényl-4-cyanocyclohexanoiques substitués.
DZ2757A1 (fr) Procédé pour la préparation d'acides hydroxamiques.
MA21273A1 (fr) Procede pour l'obtention de derives d'hydrazine utiles comme antihypertenseurs;
EP0610963A3 (en) Process for the preparation of 1,1,1,2-tetrafluoroethane.
EP0572036A3 (en) Process for the preparation of carbonyl compounds.
EP0685435A3 (en) Process for the production of inorganic powders.